Evidence map›Paper›PMID 31684173›Full record

ReviewInternational journal of molecular sciences2019

Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy.

Nina Wolska, Marcin Rozalski

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Reperfusion injury in STEMI: a double-edged sword.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Exploring bias in platelet P2YBritish journal of pharmacology · 2024
    Review
  14. Antiplatelet Effects of Selected Xanthine-Based Adenosine AInternational journal of molecular sciences · 2023
    Article
  15. Review
  16. Adenosine AMolecular biology reports · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nina WolskaDepartment of Haemostasis and Haemostatic Disorders, Chair of Biomedical Science, Medical University of Lodz, 92-215 Lodz, Poland. n.m.wolska@gmail.com.ORCID 0000-0002-8982-9741
Marcin RozalskiDepartment of Haemostasis and Haemostatic Disorders, Chair of Biomedical Science, Medical University of Lodz, 92-215 Lodz, Poland. marcin.rozalski@umed.lodz.pl.ORCID 0000-0001-5189-1243
Medical University of Lodz · PL

Funding

This work was supported within the TEAM programme of the Foundation for Polish Science co-financed by the European Union under the European Regional Development Fund TEAM/2016-1/8
6 · The paper itself

Abstract

Adenosine receptors are a subfamily of highly-conserved G-protein coupled receptors. They are found in the membranes of various human cells and play many physiological functions. Blood platelets express two (A

Indexed as

AdenosineAdenosine A2 Receptor AgonistsAnimalsBlood PlateletsCyclic AMPHumansPlatelet Aggregation InhibitorsReceptor, Adenosine A2AReceptor, Adenosine A2BThrombosisAdenosineAdenosine A2 Receptor AgonistsCyclic AMPPlatelet Aggregation InhibitorsReceptor, Adenosine A2AReceptor, Adenosine A2Badenosineadenosine receptoradenosine receptor agonistARplatelettherapy

Identifiers

PMID31684173
PMCPMC6862090
OpenAlexW2986196855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.